Nexeon Medsystems (OTCMKTS:NXNN – Get Free Report) and QT Imaging (NASDAQ:QTI – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.
Earnings & Valuation
This table compares Nexeon Medsystems and QT Imaging”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nexeon Medsystems | N/A | N/A | N/A | N/A | N/A |
| QT Imaging | $18.92 million | 3.62 | -$8.98 million | ($2.54) | -2.26 |
Profitability
This table compares Nexeon Medsystems and QT Imaging’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nexeon Medsystems | N/A | N/A | N/A |
| QT Imaging | -111.40% | N/A | -144.16% |
Institutional & Insider Ownership
24.2% of QT Imaging shares are owned by institutional investors. 61.2% of Nexeon Medsystems shares are owned by insiders. Comparatively, 28.8% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Volatility & Risk
Nexeon Medsystems has a beta of 6.98, suggesting that its share price is 598% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.1, suggesting that its share price is 110% less volatile than the S&P 500.
Analyst Ratings
This is a summary of current recommendations for Nexeon Medsystems and QT Imaging, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nexeon Medsystems | 0 | 0 | 0 | 0 | 0.00 |
| QT Imaging | 1 | 0 | 1 | 0 | 2.00 |
Given Nexeon Medsystems’ higher possible upside, research analysts clearly believe Nexeon Medsystems is more favorable than QT Imaging.
Summary
Nexeon Medsystems beats QT Imaging on 5 of the 9 factors compared between the two stocks.
About Nexeon Medsystems
Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.
About QT Imaging
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.
Receive News & Ratings for Nexeon Medsystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexeon Medsystems and related companies with MarketBeat.com's FREE daily email newsletter.
